Roche Diagnostics, one of region’s largest employers, announced Monday it is requiring COVID-19 vaccinations for all 8,000 people in its U.S. workforce, including about 4,500 in Indianapolis.
Employees will have until Nov. 15 to get fully vaccinated, or will be terminated, the company said in a statement.
About 3,000 people work on the company’s large campus at 9115 Hague Road on the northeast side and another 1,500 people work elsewhere across the region.
The operation is the North American diagnostics headquarters of Swiss pharmaceutical giant Roche Inc.
The announcement comes as the highly contagious delta variant is sweeping across Indiana and the U.S.
“Our decision, like those we’ve taken throughout the pandemic, is grounded in science,” Roche Diagnostics’ statement said. “Our top priority is to protect the health and safety of our employees and ensure business continuity. With the continued rise of the delta variant, we believe more must be done to prevent the spread of the virus at our site and the risk it poses to our people and operations.”
Roche Diagnostics becomes the latest large employer in Indianapolis, after the large hospital systems, and drugmaker Eli Lilly and Co., to lay down the vaccination requirement.
Hospitalizations due to COVID-19 continued to climb statewide over the weekend, reaching their highest number since Jan. 20, according to Monday’s report from the Indiana State Department of Health.
“We believe this is in the best interest of everyone on our campuses and the communities where we work and live, our customers and the patients we serve,” the company said.
The company sells and services machines and software to help physicians, hospitals and laboratories throughout the United States and Canada analyze data and diagnose patients. It also makes machines and test strips for diabetes patients.